Javascript must be enabled to continue!
Characterization of Hepatitis C virus circulating among injecting drug users (IDU) in Kilifi county, Kenya
View through CrossRef
Background: Hepatitis C virus is a major global health problem estimated to infect over 170 million people globally with the most common route ofinfection being injecting drug use (IDU). Treatment for HCV infection has traditionally been shown to be genotype specific; however the available drugs are still expensive and out of reach in many developing countries. To improve on monitoring, there is need to continuously document the genotypic burden and epidemiology in different populations arises. Objectives: This study aimed to determine the circulating genotypes and link the data to the socio-demographics of injecting drug users in Kilifi County along the Kenyan coastline. Methods: Using a random sampling method, this was a cross-sectional prospective study conducted among 127 injecting drug users, whereby ethical clearance was sought from Kenyatta National Hospital/ University of Nairobi Ethical and Research review committee (KNH/UON-ERC), and Reference number P366/07/2017 on 25th September 2017. Serology for HCV was done followed by nucleic acid amplification and eventual genotyping. Socio-demographic data was collected using questionnaire administered at the sites. Results: A total of 28 (23 males and 5 females) samples out of 127 samples were positive for HCV giving a prevalence of 22.1%. The modal age group was 25- 49 years. Of the positive samples, 11 were amplified by PCR, all from the male IDUs. Prevalent genotypes included genotype 1a (13%) and genotype 4a (87%). Both genotype 1a and 4a were only found in males. Conclusion: Although it is the first time to report HCV4a in Kilifi town and Mtwapa as compared to Watamu and Malindi which had both HCV1a and HCV4a. Tourists born in countries where HCV prevalence is high are supposed to be screened before accessing entry to Kilifi County. No clinical trial was conducted. The study reveals the burden of HCV infection among IDUs inKilifi County. The Government should formulate policies for intervention on testing and treatment of HCV in Kilifi County targeting IDUs in order to minimize spread to other populations.
Title: Characterization of Hepatitis C virus circulating among injecting drug users (IDU) in Kilifi county, Kenya
Description:
Background: Hepatitis C virus is a major global health problem estimated to infect over 170 million people globally with the most common route ofinfection being injecting drug use (IDU).
Treatment for HCV infection has traditionally been shown to be genotype specific; however the available drugs are still expensive and out of reach in many developing countries.
To improve on monitoring, there is need to continuously document the genotypic burden and epidemiology in different populations arises.
Objectives: This study aimed to determine the circulating genotypes and link the data to the socio-demographics of injecting drug users in Kilifi County along the Kenyan coastline.
Methods: Using a random sampling method, this was a cross-sectional prospective study conducted among 127 injecting drug users, whereby ethical clearance was sought from Kenyatta National Hospital/ University of Nairobi Ethical and Research review committee (KNH/UON-ERC), and Reference number P366/07/2017 on 25th September 2017.
Serology for HCV was done followed by nucleic acid amplification and eventual genotyping.
Socio-demographic data was collected using questionnaire administered at the sites.
Results: A total of 28 (23 males and 5 females) samples out of 127 samples were positive for HCV giving a prevalence of 22.
1%.
The modal age group was 25- 49 years.
Of the positive samples, 11 were amplified by PCR, all from the male IDUs.
Prevalent genotypes included genotype 1a (13%) and genotype 4a (87%).
Both genotype 1a and 4a were only found in males.
Conclusion: Although it is the first time to report HCV4a in Kilifi town and Mtwapa as compared to Watamu and Malindi which had both HCV1a and HCV4a.
Tourists born in countries where HCV prevalence is high are supposed to be screened before accessing entry to Kilifi County.
No clinical trial was conducted.
The study reveals the burden of HCV infection among IDUs inKilifi County.
The Government should formulate policies for intervention on testing and treatment of HCV in Kilifi County targeting IDUs in order to minimize spread to other populations.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
PREVALENCE OF HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS IN INJECTION DRUG USERS OF KHYBER PAKHTUNKHWA, AND FACTORS AFFECTING ITS OCCURRENCE
PREVALENCE OF HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS IN INJECTION DRUG USERS OF KHYBER PAKHTUNKHWA, AND FACTORS AFFECTING ITS OCCURRENCE
Objective: Our main objective was to find out the prevalence of Hepatitis C virus and Human immunodeficiency virus and its co presence in injection drug users. We have to show the ...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Adherence to COVID-19 Mitigation Measures among Kilifi and Mombasa Residents - An Observational Study in Coastal Kenya
Adherence to COVID-19 Mitigation Measures among Kilifi and Mombasa Residents - An Observational Study in Coastal Kenya
Aim: Corona Virus Disease-19 (COVID-19) pandemic led countries into engaging public health guidelines as a strategy towards preventing infections. Hand washing, social distancing a...
Patients with History of Intravenous Drug Use (IDU) with Septic Arthritis of the Foot and Ankle Have Suboptimal Hospitalization Outcomes Compared to Patients Without IDU
Patients with History of Intravenous Drug Use (IDU) with Septic Arthritis of the Foot and Ankle Have Suboptimal Hospitalization Outcomes Compared to Patients Without IDU
Category:
Infection
Introduction/Purpose:
Although intravenous drug use (IDU) is a...
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Background: We aimed to determine the awareness of referring hepatitis C virus patients to the relevant departments and the effect of the pandemic period on this subject. Methods: ...

